Medicine in the post-genomic era
Genome Medicine is an online peer-reviewed journal which publishes open access research articles of outstanding quality in all areas of medicine studied from a genomic or post-genomic perspective. The journal has a special focus on the latest technologies and findings that have an impact on the understanding and management of human health and disease.
Articles
-
Genome Medicine 2010, 2:17Genetics of mother-to-child HIV transmission
Mother-to-child HIV transmission in Malawian infants is associated with nine single nucleotide polymorphisms in six genes with roles in pregnancy, development, innate immunity and HIV-protein interaction.
-
Genome Medicine 2010, 2:16Wiki-based integration of genomic data
The development of a specialized portal for collaborative annotation and analysis of gene-phenotype networks in congenital heart defects using a Wiki platform highlights this technology’s potential for systems biology studies of other complex biological processes.
-
Genome Medicine 2010, 2:15Genomics confront antibiotic resistance
Bacterial genomics is helping to tackle antibiotic resistance by identifying new targets and increasing our understanding of resistance mechanisms.
-
Genome Medicine 2010, 2:14Developmental origins of health and disease
There is an unwillingness among public health decision makers to implement approaches based on evidence that environmental factors in early life can affect disease vulnerability in later life.
-
Genome Medicine 2010, 2:12Therapeutic potential of non-coding RNAs
Non-coding RNAs such as microRNAs and small nucleolar RNAs are implicated in human diseases ranging from cancer to neurodegenerative and metabolic diseases and offer new avenues for the development of non-invasive diagnostics and molecular therapies.
-
Genome Medicine 2010, 2:11Mapping inversion variants
While paired-end sequencing approaches have allowed the identification and mapping of inversions across the human genome, further characterization of inversion variants is required to advance our understanding of human variation and genome dynamics.
-
Genome Medicine 2010, 2:10Calculating genetic risk from multiple loci
The widely accepted unconstrained multiplicative model which combines genome wide association data for overall risk calculation is not realistic, while other models more compatible with the data are indistinguishable using currently available observed parameters.
-
Genome Medicine 2010, 2:9Multiple microRNAs muscle in on diabetes
Muscle mRNA expression is invariant with respect to diabetes status, but coordinated changes in numerous microRNAs may control protein abundance and affect skeletal muscle insulin resistance, a critical component of the disease.
Latest issue
The complete issue of Genome Medicine Volume 2 Issue 2 is now available.
Musings on genome medicine
Each issue of Genome Medicine features a regular column by David G Nathan and Stuart Orkin tackling a variety of controversial topics and providing a unique, exciting perspective on the events and developments in genomic medicine.
Quotes
High-throughput experimental and computational technologies are revolutionizing our understanding of life by enabling global systems approaches beyond classical analytical molecular and cellular biology. Genome Medicine is a timely initiative to foster this transition from the highly fragmented scientific and medical landscape to the integrative systems biology and medicine which are needed to translate fundamental discoveries into useful healthcare services for the benefit of individual patients worldwide.
Professor Charles Auffray,
Genome Medicine Section Editor
CNRS Institute of Biological Sciences, France.
Email alerts
Receive new issues alerts and journal updates
Explore this journal
Indexed by
- PubMed
- PubMed Central
- CAS
- Google Scholar
ISSN: 1756-994X